Preconditioning with high mobility group Box 1 (HMGB1) induces lipoteichoic acid (LTA) tolerance

Journal of Immunotherapy

Volumn 33, Issue 7, 2010, Pages 663-671

  Robert, Stephen M ^a   Sjodin, Hanna ^b   Fink, Mitchell P ^c   Aneja, Rajesh K ^b  

^a CHILDREN S HOSPITAL OF ALABAMA   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

high mobility group box chromosomal protein 1; lipoteichoic acid; signal transduction; tolerance; Toll like receptor 2

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; POLYMYXIN B; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR;

ACID TOLERANCE; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; DNA BINDING; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA BINDING;

ANIMALS; ANTIBODIES, BLOCKING; CELL LINE; DRUG TOLERANCE; HMGB1 PROTEIN; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; NF-KAPPA B; RECEPTORS, IMMUNOLOGIC; TEICHOIC ACIDS; TRANSCRIPTIONAL ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77955172640     PISSN: 15249557     EISSN: None     Source Type: Journal    
DOI: 10.1097/CJI.0b013e3181dcd111     Document Type: Article

References (52)

1. Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol. 1999;19:5237-5246.
2. Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 1999;285:248-251.
3. Wang H, Yang H, Czura CJ, et al. HMGB1 as a late mediator of lethal systemic inflammation. Am J Respir Crit Care Med. 2001;164(10 Pt 1):1768-1773.
4. Wang H, Yang H, Tracey KJ. Extracellular role of HMGB1 in inflammation and sepsis. J Intern Med. 2004;255:320-331.
5. Wang H, Vishnubhakat JM, Bloom O, et al. Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery. 1999;126:389-392.
6. Dumitriu IE, Baruah P, Valentinis B, et al. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J Immunol. 2005;174:7506-7515.
7. Semino C, Angelini G, Poggi A, et al. NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1. Blood. 2005;106:609-616.
8. Mullins GE, Sunden-Cullberg J, Johansson AS, et al. Activation of human umbilical vein endothelial cells leads to relocation and release of high-mobility group box chromosomal protein 1. Scand J Immunol. 2004;60:566-573.
9. 2 monolayers. Am J Physiol Cell Physiol. 2006;290:C990-C999.
10. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002;418:191-195.
11. Rovere-Querini P, Capobianco A, Scaffidi P, et al. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep. 2004;5:825-830.
12. Park JS, Svetkauskaite D, He Q, et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem. 2004;279:7370-7377.
13. Yu M, Wang H, Ding A, et al. HMGB1 signals through tolllike receptor (TLR) 4 and TLR2. Shock. 2006;26:174-179.
14. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol. 2007;81:1-5.
15. Andersson U, Wang H, Palmblad K, et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cyto-kine synthesis in human monocytes. J Exp Med. 2000;192: 565-570.
16. Sunden-Cullberg J, Norrby-Teglund A, Rouhiainen A, et al. Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit Care Med. 2005;33:564-573.
17. Angus DC, Yang L, Kong L, et al. Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis. Crit Care Med. 2007;35:1061-1067.
18. Peltz ED, Moore EE, Eckels PC, et al. HMGB1 is markedly elevated within 6 hours of mechanical trauma in humans. Shock. 2009;32:17-22.
19. Aneja RK, Tsung A, Sjodin H, et al. Preconditioning with high mobility group box 1 (HMGB1) induces lipopoly-saccharide (LPS) tolerance. J Leukoc Biol. 2008;84:1326-1334.
20. Greisman SE, Hornick RB. The nature of endotoxin tolerance. Trans Am Clin Climatol Assoc. 1975;86:43-50.
21. Draisma A, Pickkers P, Bouw MP, et al. Development of endotoxin tolerance in humans in vivo. Crit Care Med. 2009; 37:1261-1267.
22. West MA, Heagy W. Endotoxin tolerance: a review. Crit Care Med. 2002;30(1 suppl):S64-S73.
23. Munoz C, Carlet J, Fitting C, et al. Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest. 1991;88:1747-1754.
24. Fischer W. Physiology of lipoteichoic acids in bacteria. Adv Microb Physiol. 1988;29:233-302.
25. Ellingsen E, Morath S, Flo T, et al. Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of toll-like receptors and CD14. Med Sci Monit. 2002;8:BR149-BR156.
26. Jacinto R, Hartung T, McCall C, et al. Lipopolysaccharide-and lipoteichoic acid-induced tolerance and cross-tolerance: distinct alterations in IL-1 receptor-associated kinase. J Immunol. 2002;168:6136-6141.
27. Falk LA, Vogel SN. Comparison of bone marrow progenitors responsive to granulocyte-macrophage colony stimulating factor and macrophage colony stimulating factor-1. J Leukoc Biol. 1988;43:148-157.
28. Chen PC, Wheeler DS, Malhotra V, et al. A green tea-derived polyphenol, epigallocatechin-3-gallate, inhibits IkappaB kinase activation and IL-8 gene expression in respiratory epithelium. Inflammation. 2002;26:233-241.
29. Kao SJ, Lei HC, Kuo CT, et al. Lipoteichoic acid induces nuclear factor-kappaB activation and nitric oxide synthase expression via phosphatidylinositol 3-kinase, Akt, and p38 MAPK in RAW 264.7 macrophages. Immunology. 2005;115: 366-374.
30. Ziegler-Heitbrock HW, Wedel A, Schraut W, et al. Tolerance to lipopolysaccharide involves mobilization of nuclear factor-kB with predominance of p50 homodimers. J Biol Chem. 1994;269:17001-17004.
31. Takeuchi O, Hoshino K, Kawai T, et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity. 1999;11: 443-451.
32. Takeuchi O, Kaufmann A, Grote K, et al. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipo-peptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2-and MyD88-dependent signaling pathway. J Immunol. 2000;164:554-557.
33. Bell CW, Jiang W, Reich CF III, et al. The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol. 2006;291:C1318-C1325.
34. Jiang W, Bell CW, Pisetsky DS. The relationship between apoptosis and high-mobility group protein 1 release from murine macrophages stimulated with lipopolysaccharide or polyinosinic-polycytidylic acid. J Immunol. 2007;178: 6495-6503.
35. Qin S, Wang H, Yuan R, et al. Role of HMGB1 in apoptosis-mediated sepsis lethality. J Exp Med. 2006;203:1637-1642.
36. Abraham E, Arcaroli J, Carmody A, et al. HMG-1 as a mediator of acute lung inflammation. J Immunol. 2000;165: 2950-2954.
37. Andersson U, Erlandsson-Harris H, Yang H, et al. HMGB1 as a DNA-binding cytokine. J Leukoc Biol. 2002;72:1084-1091.
38. Wang H, Liao H, Ochani M, et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med. 2004;10:1216-1221.
39. Rouhiainen A, Kuja-Panula J, Wilkman E, et al. Regulation of monocyte migration by amphoterin (HMGB1). Blood. 2004; 104:1174-1182.
40. Degryse B, Bonaldi T, Scaffidi P, et al. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J Cell Biol. 2001;152:1197-1206.
41. Palumbo R, Sampaolesi M, De Marchis F, et al. Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J Cell Biol. 2004;164: 441-449.
42. Dumitriu IE, Baruah P, Bianchi ME, et al. Requirement of HMGB1 and RAGE for the maturation of human plasma-cytoid dendritic cells. Eur J Immunol. 2005;35:2184-2190.
43. Messmer D, Yang H, Telusma G, et al. High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization. J Immunol. 2004;173:307-313.
44. Lehner MD, Morath S, Michelsen KS, et al. Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different toll-like receptors independent of paracrine mediators. J Immunol. 2001;166:5161-5167.
45. Zacharowski K, Frank S, Otto M, et al. Lipoteichoic acid induces delayed protection in the rat heart: a comparison with endotoxin. Arterioscl Thromb Vasc Biol. 2000;20:1521-1528.
46. Rouhiainen A, Tumova S, Valmu L, et al. Pivotal advance: analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin). J Leukoc Biol. 2007;81:49-58.
47. Zimmermann K, Volkel D, Pable S, et al. Native versus recombinant high-mobility group B1 proteins: functional activity in vitro. Inflammation. 2004;28:221-229.
48. Hreggvidsdottir HS, Ostberg T, Wahamaa H, et al. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. J Leukoc Biol. 2009;86:655-662.
49. Cavaillon JM, Adrie C, Fitting C, et al. Endotoxin tolerance: is there a clinical relevance? J Endotoxin Res. 2003;9:101-107.
50. Park JS, Gamboni-Robertson F, He Q, et al. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol. 2006;290:C917-C924.
51. Kokkola R, Andersson A, Mullins G, et al. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol. 2005;61:1-9.
52. 3Cys is due to ablation of IL-1R-associated kinase-1. J Immunol. 2004;173:2736-2745.